Skip to main content

Head of Investor Relations

Lycia Therapeutics · Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.

$225K–$375KSouth San Francisco (Remote)G&A11-50 employeesPosted 3 days ago
Series D · $75Mraised 5 months agoled by Franklin Templeton, Eli Lilly, Janus Henderson Investors

This board only lists companies whose most recent round closed in the last 180 days.

Apply on Lycia Therapeutics’s site

Lycia Therapeutics (Nasdaq: LYCA) is a clinical-stage biotechnology company using its proprietary lysosomal targeting chimera (LYTAC) platform to discover and develop therapeutics that degrade extracellular and membrane-bound proteins. These proteins drive a wide range of difficult-to-treat diseases, including autoimmune, inflammatory, and allergic conditions. Lycia was established in 2019 in collaboration with academic founder and Nobel Laureate Carolyn Bertozzi, Ph.D., professor of chemistry and HHMI investigator at Stanford University. In October 2026, Lycia completed an initial public offering, and its common stock now trades on the Nasdaq Global Select Market under the ticker symbol “LYCA.” Lycia is headquartered in South San Francisco.

Visit https://lyciatx.com/ for more information.


Lycia is hiring a Head of Investor Relations to build the function following the company's initial public offering. Title will reflect the experience of the person hired. The role reports to the Chief Financial Officer and works closely with the Chief Executive Officer and the executive team.
This leader will manage Lycia's relationships with investors, sell-side analysts and banking partners, and will shape how the company's science, clinical progress and financial position are communicated to the market. It is a hands-on role for someone who wants to build a public company IR program from the ground up.

We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

Lycia and other biotech companies have recently noticed an increase in email and social media scams targeting job candidates in our industry. Please note Lycia will post any legitimate job openings directly on our website or through our recruitment partner, Lever. If you wish to verify the legitimacy of a job opening, you may contact us.

We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans.

Apply on Lycia Therapeutics’s site

Applications go straight to the employer. VCBacked does not sit between you and the company.

986 more roles posted in the last 48 hours

You are seeing the board after its 48-hour member window. Job Seeker opens that window and sends an alert the moment a role hits — applicants in the first 24 hours land 90 percent of interviews.

Want a wider search? JustBacked’s board of recently funded startups covers every company that closed a round in the last six months.

Back to all roles at freshly funded companies